Skip to main content

Advertisement

SpringerLink
Log in

Epstein–Barr virus–associated post-transplant lymphoproliferative disorder among long-term survivors of adults after single cord blood transplantation without antithymocyte globulin

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dierickx D, Habermann TM (2018) Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 378:549–562

    Article  CAS  Google Scholar 

  2. Al Hamed R, Bazarbachi AH, Mohty M (2019) Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities. Bone Marrow Transplant. In press

  3. Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R (2019) Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 25:1441–1449

    Article  Google Scholar 

  4. Barker JN, Martin PL, Coad JE, DeFor T, Trigg ME, Kurtzberg J, Weisdorf DJ, Wagner J (2001) Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant 7:395–399

    Article  CAS  Google Scholar 

  5. Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA, Wagner JE (2006) Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 108:2874–2880

    Article  CAS  Google Scholar 

  6. Dumas PY, Ruggeri A, Robin M, Crotta A, Abraham J, Forcade E, Bay JO, Michallet M, Bertrand Y, Socié G, Ionescu I, Gluckman E, Milpied N, Rocha V (2013) Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative study. Bone Marrow Transplant 48:253–256

    Article  CAS  Google Scholar 

  7. Sanz J, Arango M, Senent L, Jarque I, Montesinos P, Sempere A, Lorenzo I, Martín G, Moscardó F, Mayordomo E, Salavert M, Cañigral C, Boluda B, Salazar C, López-Hontangas JL, Sanz MA, Sanz GF (2014) EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases. Bone Marrow Transplant 49:397–402

    Article  CAS  Google Scholar 

  8. Naik S, Riches M, Hari P, Kim S, Chen M, Bachier C, Shaughnessy P, Hill J, Ljungman P, Battiwalla M, Chhabra S, Daly A, Storek J, Ustun C, Diaz MA, Cerny J, Beitinjaneh A, Yared J, Brown V, Page K, Dahi PB, Ganguly S, Seo S, Chao N, Freytes CO, Saad A, Savani BN, Woo Ahn K, Boeckh M, Heslop HE, Lazarus HM, Auletta JJ, Kamble RT (2019) Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study. Transpl Infect Dis 21:e13145

  9. Servais S, Hannon M, Peffault de Latour R, Socie G, Beguin Y (2017) Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications. Stem Cell Investig 4:40

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank all of the physicians and staff at the hospital and the cord blood banks in Japan for their help in this study.

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan

    Masamichi Isobe, Takaaki Konuma, Seiko Kato, Maki Oiwa-Monna, Yuta Kaito, Satoshi Takahashi & Arinobu Tojo

Authors
  1. Masamichi Isobe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takaaki Konuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seiko Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maki Oiwa-Monna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuta Kaito
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Satoshi Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Arinobu Tojo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.I. collected data, and wrote the paper. T.K. conceived the project, designed the research, collected data, analyzed data and wrote the paper. S.K. and M.O. collected data. All the other authors participated in the treatment of the patients, acquired the clinical data, and contributed to writing the paper. All authors approved the final version.

Corresponding author

Correspondence to Takaaki Konuma.

Ethics declarations

Written informed consent was acquired from all patients and healthy subjects. The Institutional Review Board of the Institute of Medical Science, University of Tokyo approved this study (30-111-B20190423).

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Isobe, M., Konuma, T., Kato, S. et al. Epstein–Barr virus–associated post-transplant lymphoproliferative disorder among long-term survivors of adults after single cord blood transplantation without antithymocyte globulin. Ann Hematol 98, 2613–2615 (2019). https://doi.org/10.1007/s00277-019-03827-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03827-3

Search

Navigation